NCE to CTM: Strategies to Bridge Discovery and Formulation

In the dynamic landscape of pharmaceutical development, a multitude of new chemical entities (NCEs) are discovered daily. This constant influx presents formulators with the ongoing challenge of addressing issues related to solubility and permeability, as well as the need for modified release delivery, often with only milligrams of active pharmaceutical ingredient (API) at their disposal.

Join us for this valuable webinar to learn how to leverage predictive tools to select formulations with the highest likelihood of success. You’ll discover key methods and solutions for expediting the screening process and facilitating seamless scale-up to clinical trial material (CTM) manufacturing